Forbion, a leading European life sciences venture capital firm, has announced the first close of its Forbion Growth Opportunities Fund II at €470m (US$503.5m) exceeding its €450m target. This new…
Forbion, a leading European life sciences venture capital firm, has announced the first close of its Forbion Growth Opportunities Fund II at €470m (US$503.5m) exceeding its €450m target. This new…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference